57,475 Shares in Agilent Technologies, Inc. $A Bought by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 57,475 shares of the medical research company’s stock, valued at approximately $7,634,000.

A number of other hedge funds have also modified their holdings of the company. Norges Bank acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $549,158,000. Bank of New York Mellon Corp lifted its stake in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after acquiring an additional 2,440,360 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares during the period. Finally, Findlay Park Partners LLP purchased a new position in Agilent Technologies during the second quarter worth approximately $174,281,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Jefferies Financial Group started coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and cut their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Barclays boosted their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Price Performance

A stock opened at $155.16 on Thursday. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.51. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $43.82 billion, a price-to-earnings ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The business has a fifty day moving average of $139.16 and a two-hundred day moving average of $126.65.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.